AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PAVmed Inc. Director's Dealing 2023

May 1, 2023

35221_dirs_2023-05-01_4633b354-cf4c-4f2b-b634-b21905adc4ce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PAVmed Inc. (PAVM)
CIK: 0001624326
Period of Report: 2022-05-04

Reporting Person: O'Neil Shaun (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-04	Common stock	F	25935	$1.38	Disposed	265469	Direct

Footnotes

F1: Payment of payroll withholding tax liability using a portion of securities received from the company.

F2: Includes shares purchased pursuant to the company's Employee Stock Purchase Plan in transactions exempt from Section 16(a) reporting obligations.